Glycolysis Metabolism in Neurodegeneration is a critical component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Brain glucose metabolism is essential for neuronal function, with glycolysis providing rapid energy and metabolic intermediates. Cerebral glucose hypometabolism is an early hallmark of Alzheimer's disease and contributes to other neurodegenerative conditions.
The glycolytic pathway converts glucose to pyruvate:
- Input: Glucose
- Output: Pyruvate, ATP, NADH
- Location: Cytoplasm of all cells
| Enzyme |
Step |
Regulation |
| Hexokinase (HK) |
Glucose → G6P |
Inhibited by G6P |
| Phosphofructokinase (PFK) |
F6P → F1,6BP |
AMP/ATP, citrate |
| Pyruvate kinase (PK) |
PEP → Pyruvate |
Allosteric activation |
- Glucose uptake: GLUT1 (BBB), GLUT3 (neurons)
- Astrocyte-neuron lactate shuttle: Critical for neurotransmission
- Alternative fuels: Ketone bodies, lactate
flowchart TD
A[Glucose] --> B[HK: Glucose-6-phosphate] -->
B --> C[PGI: Fructose-6-phosphate] -->
C --> D[PFK: Fructose-1,6-bisphosphate] -->
D --> E[ALD: Dihydroxyacetone phosphate<br/>Glyceraldehyde-3-phosphate] -->
E --> F[TPI: Glyceraldehyde-3-phosphate] -->
F --> G[GAPDH: 1,3-Bisphosphoglycerate] -->
G --> H[PGK: 3-Phosphoglycerate] -->
H --> I[PGM: 2-Phosphoglycerate] -->
I --> J[PK: Pyruvate] -->
J --> K[Acetyl-CoA<br/>or Lactate] -->
A -.-> L[ATP: -2] -->
G -.-> M[ATP: +2] -->
J -.-> N[ATP: +2]
| Change |
Effect |
| ↓ GLUT1/3 |
Reduced glucose uptake |
| ↓ PFK activity |
Impaired glycolysis |
| ↓ PDH activity |
Reduced acetyl-CoA |
| ↓ Mitochondrial function |
Energy failure |
flowchart TD
A[Glucose] --> B[Astrocyte GLUT1] -->
B --> C[Glycolysis] -->
C --> D[Lactate production] -->
D --> E[Monocarboxylate transporter] -->
E --> F[Neuronal uptake] -->
F --> G[Neuronal oxidation] -->
G --> H[ATP production] -->
C --> I[Glutamate uptake] -->
I --> J[Na+/K+ ATPase] -->
J --> C
flowchart LR
A[Glucose hypometabolism] --> B[ATP depletion] -->
B --> C[Synaptic failure] -->
C --> D[Cognitive decline] -->
B --> E[Ion pump dysfunction] -->
E --> F[Excitotoxicity)
F --> D
B --> G[Proteostasis failure] -->
G --> H[Protein aggregation)
H --> D
| Finding |
Brain Region |
Diagnostic Use |
| ↓ Glucose metabolism |
Posterior cingulate, parietal |
FDG-PET biomarker |
| ↓ PFK activity |
Cortex, hippocampus |
Research |
| ↓ GLUT1/3 |
BBB, neurons |
Pathology |
| ↑ Lactate |
CSF, brain tissue |
Biomarker |
- Amyloid interaction: Aβ inhibits PFK
- Tau pathology: Affects glucose transporters
- Vascular contributions: CBF reduction
- Insulin resistance: Type 3 diabetes hypothesis
| Target |
Approach |
Status |
| GLUT1 |
Increase expression |
Preclinical |
| PFK activators |
Enhance glycolysis |
Research |
| Insulin signaling |
Intranasal insulin |
Clinical trials |
| Ketogenic diet |
Alternative fuel |
Clinical trials |
- Basal ganglia: Reduced glucose metabolism
- Substantia nigra: Mitochondrial complex I deficiency
- Widespread: White matter hypometabolism
| Change |
Effect |
| ↓ Complex I |
Impaired oxidative phosphorylation |
| ↑ Glycolysis compensation |
Metabolic adaptation |
| ↓ Mitochondrial function |
ATP depletion |
| ↑ Oxidative stress |
Further damage |
| Approach |
Rationale |
| Ketogenic diet |
Alternative energy |
| Metabolic supplements |
Support glycolysis |
| Exercise |
Improve metabolism |
- Hypermetabolism: Increased energy expenditure
- Motor neurons: Vulnerable to metabolic stress
- Astrocytes: Impaired lactate production
| Finding |
Implication |
| ↓ Glucose uptake |
Energy failure |
| ↑ Resting energy expenditure |
Cachexia risk |
| Altered lactate metabolism |
ANLS dysfunction |
- 系统性代谢异常: Whole-body metabolic changes
- HTT mutation: Affects energy homeostasis
- 纹状体选择性: Striatal vulnerability
| Change |
Brain Region |
| ↓ Glucose metabolism |
Striatum, cortex |
| ↑ Lactate |
Basal ganglia |
| ↓ PFK |
Motor cortex |
- Metabolic Enhancers
| Compound |
Target |
Status |
| L-carnitine |
Fatty acid oxidation |
Clinical trials |
| Alpha-lipoic acid |
Mitochondrial function |
Research |
| CoQ10 |
Electron transport chain |
Clinical trials |
- Ketogenic Approaches
| Approach |
Mechanism |
Status |
| Ketogenic diet |
Ketone as fuel |
Clinical trials |
| Ketone esters |
Exogenous ketones |
Phase I/II |
| MCT oil |
Ketone production |
Research |
- Glucose Transport Modulation
| Target |
Approach |
Status |
| GLUT1 |
Gene therapy |
Preclinical |
| GLUT3 |
Expression enhancers |
Research |
| SGLT2 |
Glucose regulation |
Research |
- Blood-brain barrier penetration
- Metabolic adaptation
- Individual variability
- Long-term safety
The study of Glycolysis Metabolism In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cunnane SC, et al. (2020). Brain energy metabolism in Alzheimer's disease. Journal of Neurochemistry.
- Mergenthaler P, et al. (2013). Sugar for the brain. Trends in Neurosciences.
- Pellerin L, Magistretti PJ. (1994). Glutamate uptake stimulates astrocyte glycolysis. Journal of Cerebral Blood Flow & Metabolism.
- Mosconi L, et al. (2008). Hypometabolism in AD. Neurology.
- Hertz L, et al. (2015). Astrocyte-neuron lactate shuttle. Developmental Neuroscience.
- Camandola S, Mattson MP. (2017). Brain metabolism in health and disease. EMBO Reports.
- Zhou Y, et al. (2015). FDG-PET in AD and PD. Journal of Alzheimer's Disease.
- Arnold SE, et al. (2018). Brain insulin resistance in AD. Neurobiology of Disease.
- Schön M, et al. (2019). Ketogenic diet in neurodegeneration. Nutritional Neuroscience.
- Yao J, et al. (2011). Mitochondrial dysfunction in AD. Journal of Alzheimer's Disease.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
75% |
Overall Confidence: 39%